Profile

Every navigable entity, fully sourced. Search, then drill.

drug (3,117)company (1,977)trial (4,168)indication (1,856)person (8,176)

Trials

60 shown
"Art Therapy" in Acute Psychiatrytrial
"Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"trial
"Extended" (Alternate Day) Antipsychotic Dosingtrial
"InMotion" - Physical Training With Creative Movement as an Intervention for Adults With Schizophreniatrial
"Manual Dexterity and Oculomotor Control in Schizophrenia"trial
"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"trial
10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individualstrial
12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patientstrial
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarceratedtrial
18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophreniatrial
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptomstrial
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)trial
24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Studytrial
24-Week Open Label Extension to a Randomized, 6-Week Double Blind, Placebo Controlled Study, to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliperidone in the Treatment of Geriatric Subjects With Schizophreniatrial
28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Yearstrial
3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individualstrial
40 Hz Visual Stimulation as an Intervention in Schizophreniatrial
5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophreniatrial
50 Hz vs. 25 Hz Magnetic Seizure Therapy for Schizophreniatrial
52-week Open Label Safety-Tolerability Studytrial
5HT3 Antagonism and Auditory Gating in Schizophreniatrial
6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)trial
6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)trial
6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)trial
7-week Study With CT-155 in People With Schizophreniatrial
A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.trial
A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolar Disordertrial
A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.trial
A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and Relapsetrial
A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapytrial
A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophreniatrial
A 52 Week Open Label Extension Trial Following the Recurrence Prevention Study R076477-SCH-301 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia.trial
A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305.trial
A 52-week, Open-label Extension Study Following a 6-week, Double-blind, Placebo- and Active- Controlled Study (R076477-SCH-303) to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophreniatrial
A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophreniatrial
A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophreniatrial
A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patientstrial
A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophreniatrial
A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophreniatrial
A Bioequivalence Study of 15 mg ER OROS Paliperidonetrial
A Bioequivalence Study of PP3M in Patients With Schizophreniatrial
A Biological Signature for the Early Differential Diagnosis of Psychosistrial
A Brief Community Linkage Intervention for Dually Diagnosed Individualstrial
A Cannabis Harm Reduction e-Intervention for Young Cannabis Users With Early Psychosistrial
A Case Series of Culturally-adapted CBTp for Black People in the UKtrial
A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophreniatrial
A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophreniatrial
A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Dosestrial
A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standardtrial
A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophreniatrial
A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophreniatrial
A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medicationtrial
A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatmenttrial
A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophreniatrial
A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imagingtrial
A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia.trial
A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophreniatrial
A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.trial
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophreniatrial
A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophreniatrial